Table of Contents
Executive Summary
1 Industry Overview of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
1.1 Definition of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
1.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment by Type
1.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Hemostats
1.2.3 Internal Tissue Sealants
1.2.4 Adhesion Barriers
1.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment by Applications
1.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics & Trauma Centers
1.3.4 Ambulatory Surgical Centers
1.4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Overall Market
1.4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue (2014-2025)
1.4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production (2014-2025)
1.4.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.5 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.6 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.7 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
1.4.8 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
2.3 Manufacturing Process Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
2.4 Industry Chain Structure of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
3 Development and Manufacturing Plants Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
3.1 Capacity and Commercial Production Date
3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production and Capacity Analysis
4.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Analysis
4.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price Analysis
4.4 Market Concentration Degree
5 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Regional Market Analysis
5.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Regions
5.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Regions
5.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Regions
5.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Regions
5.3 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.3.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.3.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.4.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.4.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.5 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.5.1 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.5.2 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.6 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.6.1 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.6.2 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.7 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.7.1 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.7.2 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
5.8 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Analysis
5.8.1 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production
5.8.2 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Import and Export
6 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment Market Analysis (by Type)
6.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production by Type
6.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Type
6.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Price by Type
7 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Segment Market Analysis (by Application)
7.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption by Application
7.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Consumption Market Share by Application (2014-2019)
8 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Major Manufacturers Analysis
8.1 Baxter
8.1.1 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.1.2 Baxter Product Introduction, Application and Specification
8.1.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Ethicon
8.2.1 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.2.2 Ethicon Product Introduction, Application and Specification
8.2.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 B. Braun Melsungen
8.3.1 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.3.2 B. Braun Melsungen Product Introduction, Application and Specification
8.3.3 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Sanofi
8.4.1 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.4.2 Sanofi Product Introduction, Application and Specification
8.4.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 C. R. Bard
8.5.1 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.5.2 C. R. Bard Product Introduction, Application and Specification
8.5.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Integra Lifesciences
8.6.1 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.6.2 Integra Lifesciences Product Introduction, Application and Specification
8.6.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Cryolife
8.7.1 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.7.2 Cryolife Product Introduction, Application and Specification
8.7.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Tissuemed
8.8.1 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.8.2 Tissuemed Product Introduction, Application and Specification
8.8.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Cohera Medical
8.9.1 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.9.2 Cohera Medical Product Introduction, Application and Specification
8.9.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Pfizer
8.10.1 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production Sites and Area Served
8.10.2 Pfizer Product Introduction, Application and Specification
8.10.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market
9.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trend Analysis
9.1.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size (Volume and Value) Forecast 2019-2025
9.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Regional Market Trend
9.2.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.3 China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.4 Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.5 Southeast Asia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.2.6 India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Forecast 2019-2025
9.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trend (Product Type)
9.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
【掲載企業】
Baxter、Ethicon、B. Braun Melsungen、Sanofi、C. R. Bard、Integra Lifesciences、Cryolife、Tissuemed、Cohera Medical、Pfizer